Eric Jutkowitz1, Robert L Kane2, Joseph E Gaugler3, Richard F MacLehose4, Bryan Dowd2, Karen M Kuntz2. 1. Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island. 2. Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, Minnesota. 3. School of Nursing, University of Minnesota, Minneapolis, Minnesota. 4. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Abstract
OBJECTIVES: To estimate the cost of dementia and the extra cost of caring for someone with dementia over the cost of caring for someone without dementia. DESIGN: We developed an evidence-based mathematical model to simulate disease progression for newly diagnosed individuals with dementia. Data-driven trajectories of cognition, function, and behavioral and psychological symptoms were used to model disease progression and predict costs. Using modeling, we evaluated lifetime and annual costs of individuals with dementia, compared costs of those with and without clinical features of dementia, and evaluated the effect of reducing functional decline or behavioral and psychological symptoms by 10% for 12 months (implemented when Mini-Mental State Examination score ≤21). SETTING: Mathematical model. PARTICIPANTS: Representative simulated U.S. incident dementia cases. MEASUREMENTS: Value of informal care, out-of-pocket expenditures, Medicaid expenditures, and Medicare expenditures. RESULTS: From time of diagnosis (mean age 83), discounted total lifetime cost of care for a person with dementia was $321,780 (2015 dollars). Families incurred 70% of the total cost burden ($225,140), Medicaid accounted for 14% ($44,090), and Medicare accounted for 16% ($52,540). Costs for a person with dementia over a lifetime were $184,500 greater (86% incurred by families) than for someone without dementia. Total annual cost peaked at $89,000, and net cost peaked at $72,400. Reducing functional decline or behavioral and psychological symptoms by 10% resulted in $3,880 and $680 lower lifetime costs than natural disease progression. CONCLUSION: Dementia substantially increases lifetime costs of care. Long-lasting, effective interventions are needed to support families because they incur the most dementia cost.
OBJECTIVES: To estimate the cost of dementia and the extra cost of caring for someone with dementia over the cost of caring for someone without dementia. DESIGN: We developed an evidence-based mathematical model to simulate disease progression for newly diagnosed individuals with dementia. Data-driven trajectories of cognition, function, and behavioral and psychological symptoms were used to model disease progression and predict costs. Using modeling, we evaluated lifetime and annual costs of individuals with dementia, compared costs of those with and without clinical features of dementia, and evaluated the effect of reducing functional decline or behavioral and psychological symptoms by 10% for 12 months (implemented when Mini-Mental State Examination score ≤21). SETTING: Mathematical model. PARTICIPANTS: Representative simulated U.S. incident dementia cases. MEASUREMENTS: Value of informal care, out-of-pocket expenditures, Medicaid expenditures, and Medicare expenditures. RESULTS: From time of diagnosis (mean age 83), discounted total lifetime cost of care for a person with dementia was $321,780 (2015 dollars). Families incurred 70% of the total cost burden ($225,140), Medicaid accounted for 14% ($44,090), and Medicare accounted for 16% ($52,540). Costs for a person with dementia over a lifetime were $184,500 greater (86% incurred by families) than for someone without dementia. Total annual cost peaked at $89,000, and net cost peaked at $72,400. Reducing functional decline or behavioral and psychological symptoms by 10% resulted in $3,880 and $680 lower lifetime costs than natural disease progression. CONCLUSION:Dementia substantially increases lifetime costs of care. Long-lasting, effective interventions are needed to support families because they incur the most dementia cost.
Authors: Tazio Vanni; Jonathan Karnon; Jason Madan; Richard G White; W John Edmunds; Anna M Foss; Rosa Legood Journal: Pharmacoeconomics Date: 2011-01 Impact factor: 4.981
Authors: Vincent Mor; Jacqueline Zinn; Pedro Gozalo; Zhanlian Feng; Orna Intrator; David C Grabowski Journal: Health Aff (Millwood) Date: 2007 Nov-Dec Impact factor: 6.301
Authors: Kenneth M Langa; Brenda L Plassman; Robert B Wallace; A Regula Herzog; Steven G Heeringa; Mary Beth Ofstedal; James R Burke; Gwenith G Fisher; Nancy H Fultz; Michael D Hurd; Guy G Potter; Willard L Rodgers; David C Steffens; David R Weir; Robert J Willis Journal: Neuroepidemiology Date: 2005-08-15 Impact factor: 3.282
Authors: Duane L Beekly; Erin M Ramos; William W Lee; Woodrow D Deitrich; Mary E Jacka; Joylee Wu; Janene L Hubbard; Thomas D Koepsell; John C Morris; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2007 Jul-Sep Impact factor: 2.703
Authors: Eric B Larson; Marie-Florence Shadlen; Li Wang; Wayne C McCormick; James D Bowen; Linda Teri; Walter A Kukull Journal: Ann Intern Med Date: 2004-04-06 Impact factor: 25.391
Authors: Eric Jutkowitz; Courtney H Van Houtven; Brenda L Plassman; Vincent Mor Journal: Alzheimer Dis Assoc Disord Date: 2020 Jan-Mar Impact factor: 2.703
Authors: Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Erin Sundermann; Christina G Wong; Joel Eppig; Madeleine L Werhane; Lisa Delano-Wood; Mark W Bondi Journal: Alzheimer Dis Assoc Disord Date: 2020 Jan-Mar Impact factor: 2.703